Since 1966, METCO has brought students from Boston to schools in nearby suburbs. A recent study finds that it boosts their ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ...

Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates.

Boston Scientific Stock Prediction For 2024 Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the ...

As part of the partnership, Catapult Learning was named a select provider of professional development and coaching services to ensure that educators across the country are equipped to effectively ...

Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third quarter powered by the launch of its Farapulse system for atrial ...